`Start
`End
`Period
`Sort
`
`TOTAL_INTEGRATED_UNITS
`1/1/2009
`12/31/2018
`Per=Q
`Sort=A
`
`MOLECULE_TICKER
`RX_01643 Comdty
`RX_01643 Comdty
`RX_01643 Comdty
`
`DRUG_NAME
`ZENAPAX
`ZENAPAX
`ZINBRYTA
`
`MOLECULE_NAME
`DACLIZUMAB
`DACLIZUMAB
`DACLIZUMAB
`
`PRODUCT_INDICATOR
`B
`B
`B
`
`DRUG_STRENGTH
`5MG/ML
`5MG/ML
`150MG/ML
`
`DRUG_PACKAGE_SIZE
`5.000
`5.000
`1.000
`
`DRUG_FORM
`VIALS INJECTABLE
`VIALS INJECTABLE
`SYRINGES DISPOSABLE
`
`Biogen Exhibit 2111
`Mylan v. Biogen
`IPR 2018-01403
`
`Page 1 of 3
`
`
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`2013
`2013
`2013
`2012
`2012
`2012
`2012
`2011
`2011
`2011
`2011
`2010
`2010
`2010
`2010
`2009
`2009
`2009
`2009
`Q1_2009 Q2_2009 Q3_2009 Q4_2009 Q1_2010 Q2_2010 Q3_2010 Q4_2010 Q1_2011 Q2_2011 Q3_2011 Q4_2011 Q1_2012 Q2_2012 Q3_2012 Q4_2012 Q1_2013 Q2_2013 Q3_2013
`
`MANUFACTURER_NAME
`REPACKER
`ROCHE
`ABBVIE US LLC
`
`65725
`
`65735
`
`84020
`
`68139
`
`5485
`
`175
`
`165
`
`80
`
`95
`
`75
`
`15
`
`Page 2 of 3
`
`
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`2018
`2018
`2018
`2018
`2017
`2017
`2017
`2017
`2016
`2016
`2016
`2016
`2015
`2015
`2015
`2015
`2014
`2014
`2014
`2014
`2013
`Q4_2013 Q1_2014 Q2_2014 Q3_2014 Q4_2014 Q1_2015 Q2_2015 Q3_2015 Q4_2015 Q1_2016 Q2_2016 Q3_2016 Q4_2016 Q1_2017 Q2_2017 Q3_2017 Q4_2017 Q1_2018 Q2_2018 Q3_2018 Q4_2018
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`188
`
`1242
`
`2389
`
`3077
`
`3010
`
`2948
`
`2491
`
`15
`
`Page 3 of 3
`
`